SU685156A3 - Method of obtaining n-(5-tetrazolyl)-1-oxo-1h-pyramido-(1,2-a)-quinolin-2-carboxamide - Google Patents
Method of obtaining n-(5-tetrazolyl)-1-oxo-1h-pyramido-(1,2-a)-quinolin-2-carboxamideInfo
- Publication number
- SU685156A3 SU685156A3 SU762379567A SU2379567A SU685156A3 SU 685156 A3 SU685156 A3 SU 685156A3 SU 762379567 A SU762379567 A SU 762379567A SU 2379567 A SU2379567 A SU 2379567A SU 685156 A3 SU685156 A3 SU 685156A3
- Authority
- SU
- USSR - Soviet Union
- Prior art keywords
- carboxamide
- oxo
- tetrazolyl
- pyramido
- quinolin
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/04—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
Landscapes
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Engineering & Computer Science (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pulmonology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Immunology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
Description
(54) СПОСОБ ПОЛУЧЕНИЯ N-(5-TETPA3O n)-l-OKCO-lH-ПИРИМИДО- U-A -ХИНОЛИН-2- КАРБОКСАМИДА карбодиимидов примен ют, например, дициклогексилкарбодиимвд , 1-циклогексил-З- (2-морфолинометил )-карбодиимид или хлоргвдрат 1-этил-3- (З-диметиламинопропил) -карбодиимид. Примерами растворителей вл ютс N,N-диметилформамид (ДМФА), тетрагидрофураи, диоксан, дюоюрметан, нитрометан или ацетонитрил . Взаимодействие кислоты с конденсирующим агентом провод т при 20-110°С. Промежуточное соединение затем вступает в реакцию с 5-аминотетразолом при 20-ИО°С. Мол рное отношение кислота : конденсирующий агент : 5-аминотетразол обычно 1:1:1 - 1:1, 1:1, 1. Удовлетворительным вл етс из .бьггок 10 мол.%. Все реагенты можно вводить сразу, а не по част м. Однако при предварительном образовании промежуточного соединени обычно выход целевых М-(5-тетразолш1)-амидов повышаетс . Пример. М-(5-Тетразолил)-1-оксо-1Н-6-метоксипиримидо- 1,2-а} -хинолин-2-карбоксамид . Смесь 1-оксо-1Н-6-метоксипирнм1здо- 1,2-aJ-хинолин-2-карбоновой кислоты (540 мг, 2,0 ммоль) и N,N -карбонил-диимидазола (357 мг, 2,2 ммоль) в ДМФА (15 мл) переме шивают и нагревают на паровой бане в течение 14 мин. После нагревани в течение примерно 5 мин происходит осветление раствора, а затем образуетс осадок. Перемешивают еще 45 мин при комнатной температуре, обрабатывают 5-аминотетразолом (187 мг, 2,2 ммоль), нагревают на паровой бане в течение 40 мин, охлаж ают и фильтруют, получа 540 мг желтого тверого вещества, т.пл. 220°С (разл.). Продукт раствор ют в гор чем ДМФА (200 мг продукта на 20 мл ДМФА, фильтруют. гор чий раствор, охлаждают фильтрат, выпавие желтые кристаллы отфилыровьшают и вы сушивают, Т.Ш1. (разл.). Вычислено,%: С 53,41; Н 3,29; N 29,07 CisHjiN Os. Найдено,%: С 53,12; Н 3,67; N 28,75. Аналогично получают соединени общей формулы 0 V-y Q -Jin-( Ij перечисленные в табл. 1, и табл. 2. Пример 2. Продукты, полученные как в примере 1, превращают в соли натри , кали , аммони , кальци , магни и алюмини , тризтипамина , три-н-бутиламина, пиперидина, триэтаноламина , даэпшаминоэтиламина, пирролидина и N,N-дибeнзилэп лeндиaминa при взаимодействии с эквивалентным количеством гидроокиси металла , гидроокиси аммони или амина в воде или зханоле с последующим фильтрованием соли , если она нерастворима, или упариванием растворител , если соль растворима в нем.(54) METHOD FOR PRODUCING N- (5-TETPA3O n) -l-OKCO-lH-pyrimido UA quinoline-2- carboxamide carbodiimides is used, for example, ditsiklogeksilkarbodiimvd, 1-cyclohexyl-Z- (2-morpholinomethyl) carbodiimide or 1-ethyl-3- (3-dimethylaminopropyl) -carbodiimide chlorhydrate. Examples of solvents are N, N-dimethylformamide (DMF), tetrahydrofuran, dioxane, dyuroyurmethane, nitromethane or acetonitrile. The reaction of the acid with the condensing agent is carried out at 20-110 ° C. The intermediate compound then reacts with 5-aminotetrazole at 20 IO ° C. The molar ratio of acid: condensing agent: 5-aminotetrazole is usually 1: 1: 1 - 1: 1, 1: 1, 1. A satisfactory is 10 mol%. All reagents can be administered directly, and not in portions. However, with the preliminary formation of an intermediate, usually the yield of the desired M- (5-tetrazol-1) -amides increases. Example. M- (5-Tetrazolyl) -1-oxo-1H-6-methoxypyrimido-1,2-a} -quinoline-2-carboxamide. A mixture of 1-oxo-1H-6-methoxypyrm1iso-1,2-aJ-quinoline-2-carboxylic acid (540 mg, 2.0 mmol) and N, N -carbonyl-diimidazole (357 mg, 2.2 mmol) in DMF (15 ml) is stirred and heated on the steam bath for 14 minutes. After heating for about 5 minutes, the solution is clarified, and a precipitate is formed. The mixture is stirred for 45 minutes at room temperature, treated with 5-aminotetrazole (187 mg, 2.2 mmol), heated on the steam bath for 40 minutes, cooled and filtered to obtain 540 mg of a yellow solid, mp. 220 ° C (decomp.). The product is dissolved in hot DMF (200 mg of product per 20 ml of DMF, filtered. Hot solution, the filtrate is cooled, the yellow crystals are precipitated and dried, T.Sh1. (Dec.). Calculated,%: C 53.41 ; H 3.29; N 29.07 CisHjiN Os. Found: C 53.12; H 3.67; N 28.75. Similarly, compounds of the general formula 0 Vy Q -Jin- are obtained (Ij listed in Table 1 , and Table 2. Example 2. The products obtained as in Example 1 are converted to the salts of sodium, potassium, ammonium, calcium, magnesium and aluminum, triztypamine, tri-n-butylamine, piperidine, triethanolamine, daepshaminoethylamine, pyrrolidine and N, N-dibenzi ep lendiamina by reaction with an equivalent amount of metal hydroxide, ammonium hydroxide or amine in water or salt zhanole followed by filtration, if insoluble, or by evaporation of the solvent if the salt is soluble therein.
Таблица 2 ФорМула изобретени Способ получени N- {5-тетразолил)- 1-оксо-пиримидо- 1,2-а1-хшюлин-2- карбоксамида общей формулы RI где RI и R2 - водород, Cj-Cs - алкил, GI-GS - алкоксигруппа, фтор или хлор, Вз - хлор, бром или Cj-Cs апкоксигруппа. отличающийс тем,что кислоту общей форм где RI - Яз - как указано выше, подвергают взаимоде11ствию с 5-аминотетразолом в среде инертного растворител при 20110°С в присутс1БЮ1 конденсирующего areirra, такого, как ,N-кapбoш лдинмидaзoл, N,N карбонилди-5-триазин, зтоксиацетилен, 1,1-ДИ (слордиэтилоЕый эфир, Д11фенилкетен-п-толш1имин , N-оксифталимид, N-оксипиперидин, этиленхлорфосфит , диэтилэтиленпирофосфит, Nэтш1-5-фегашизоксазолий-3-сульфонат , фенилфосфорди- (1-имидазолат), дизткгщиаиамид или карбодимиды, с вьщелением целевого продукта . Источники 5шформащ1И, прин тые во внимание при экспертизе 1. L F. Fieser, М. Fleser. Reagents oY organic Synthesis, New-Jerk-London-Sydney, Jonn .Wiley ond sons, Jnc, 1967, p. 114TABLE 2 Formula of the invention. Method for the preparation of N- {5-tetrazolyl) -1-oxo-pyrimido-1,2-a1-chshulin-2-carboxamide of the general formula RI where RI and R2 are hydrogen, Cj-Cs is alkyl, GI-GS - alkoxy group, fluorine or chlorine; B 6 - chlorine, bromine or Cj-Cs apkoxy group. characterized in that the acid of the general form where RI is Haz — as indicated above, is reacted with 5-aminotetrazole in an inert solvent at 20110 ° C in the presence of 1BY1 condensing areirra, such as, N-carbohydrate imidazole, N, N carbonyldi-5 -triazine, ztoxyacetylene, 1,1-DI (compound diethyl ether, D11-phenyl-4-a-3-a-3-ay-3, N-hydroxyphthalimide, N-hydroxypiperidine, ethylene chlorophosphite, diethylethylen pyrophosphite, Natsh1-5-phygasisoxazole 3-3 diesel carbamide or carbodimides, with the release of the target product. Sources 5shformshch1, p yn Tide into account in the examination 1. L F. Fieser, M. Fleser. Reagents oY organic Synthesis, New-Jerk-London-Sydney, Jonn .Wiley ond sons, Jnc, 1967, p. 114
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US60103975A | 1975-08-01 | 1975-08-01 |
Publications (1)
Publication Number | Publication Date |
---|---|
SU685156A3 true SU685156A3 (en) | 1979-09-05 |
Family
ID=24406004
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
SU762379567A SU685156A3 (en) | 1975-08-01 | 1976-03-12 | Method of obtaining n-(5-tetrazolyl)-1-oxo-1h-pyramido-(1,2-a)-quinolin-2-carboxamide |
Country Status (31)
Country | Link |
---|---|
JP (1) | JPS5231098A (en) |
AR (1) | AR213099A1 (en) |
AT (1) | AT351028B (en) |
AU (1) | AU497412B2 (en) |
BE (1) | BE843952A (en) |
BG (1) | BG31229A3 (en) |
CA (1) | CA1060441A (en) |
CH (1) | CH616679A5 (en) |
CS (1) | CS195731B2 (en) |
DD (1) | DD126735A5 (en) |
DE (1) | DE2630469C2 (en) |
DK (1) | DK311276A (en) |
EG (1) | EG12424A (en) |
ES (1) | ES449777A1 (en) |
FI (1) | FI59409C (en) |
FR (1) | FR2319363A1 (en) |
GB (1) | GB1500666A (en) |
GR (1) | GR60549B (en) |
HU (1) | HU172063B (en) |
IE (1) | IE43028B1 (en) |
IL (1) | IL49924A (en) |
LU (1) | LU75369A1 (en) |
NL (1) | NL163514C (en) |
NO (1) | NO139786C (en) |
NZ (1) | NZ181317A (en) |
PH (1) | PH12132A (en) |
PT (1) | PT65349B (en) |
SE (1) | SE414175B (en) |
SU (1) | SU685156A3 (en) |
YU (1) | YU185076A (en) |
ZA (1) | ZA763876B (en) |
Families Citing this family (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE2720085A1 (en) | 1977-05-05 | 1978-11-16 | Hoechst Ag | PYRIMIDO (6.1-A) ISOCHINOLIN-2-ON DERIVATIVES |
US4127720A (en) * | 1977-09-21 | 1978-11-28 | Bristol-Myers Company | Pyrimido[2,1-a]isoquinoline derivatives having antiallergy activity |
US4192944A (en) * | 1978-04-03 | 1980-03-11 | Bristol-Myers Company | Optionally substituted 4-oxo-4H-pyrido[1,2-a]pyrimidine-3-N-(1H-tetrazol-4-yl)carboxamides and their use as antiallergy agents |
JPS55138593U (en) * | 1979-03-27 | 1980-10-02 | ||
AU5533996A (en) * | 1996-04-04 | 1997-10-29 | University Of Nebraska Board Of Regents | Synthetic triple helix-forming compounds |
-
1976
- 1976-03-12 SU SU762379567A patent/SU685156A3/en active
- 1976-04-06 IE IE714/76A patent/IE43028B1/en unknown
- 1976-06-21 SE SE7607099A patent/SE414175B/en unknown
- 1976-06-28 GR GR51134A patent/GR60549B/en unknown
- 1976-06-28 IL IL49924A patent/IL49924A/en unknown
- 1976-06-28 NZ NZ181317A patent/NZ181317A/en unknown
- 1976-06-29 CA CA255,988A patent/CA1060441A/en not_active Expired
- 1976-06-29 ZA ZA763876A patent/ZA763876B/en unknown
- 1976-07-01 PH PH18640A patent/PH12132A/en unknown
- 1976-07-07 DE DE2630469A patent/DE2630469C2/en not_active Expired
- 1976-07-09 PT PT65349A patent/PT65349B/en unknown
- 1976-07-09 BG BG7633712A patent/BG31229A3/en unknown
- 1976-07-09 HU HU76PI00000528A patent/HU172063B/en unknown
- 1976-07-09 FI FI762016A patent/FI59409C/en not_active IP Right Cessation
- 1976-07-09 NO NO762411A patent/NO139786C/en unknown
- 1976-07-09 FR FR7621101A patent/FR2319363A1/en active Granted
- 1976-07-09 DK DK311276A patent/DK311276A/en not_active Application Discontinuation
- 1976-07-09 BE BE1007495A patent/BE843952A/en not_active IP Right Cessation
- 1976-07-09 AU AU15784/76A patent/AU497412B2/en not_active Expired
- 1976-07-09 NL NL7607618.A patent/NL163514C/en not_active IP Right Cessation
- 1976-07-12 JP JP51082862A patent/JPS5231098A/en active Pending
- 1976-07-12 LU LU75369A patent/LU75369A1/xx unknown
- 1976-07-12 CS CS764616A patent/CS195731B2/en unknown
- 1976-07-12 DD DD193810A patent/DD126735A5/xx unknown
- 1976-07-12 CH CH891276A patent/CH616679A5/en not_active IP Right Cessation
- 1976-07-12 ES ES449777A patent/ES449777A1/en not_active Expired
- 1976-07-12 AT AT512676A patent/AT351028B/en not_active IP Right Cessation
- 1976-07-12 EG EG426/76A patent/EG12424A/en active
- 1976-07-14 GB GB29181/76A patent/GB1500666A/en not_active Expired
- 1976-07-19 AR AR263987A patent/AR213099A1/en active
- 1976-07-27 YU YU01850/76A patent/YU185076A/en unknown
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US2910488A (en) | Aniline derivatives | |
IL45654A (en) | 6-substituted amino-s-triazolo(4,3-b)pyridazine derivatives | |
SU685156A3 (en) | Method of obtaining n-(5-tetrazolyl)-1-oxo-1h-pyramido-(1,2-a)-quinolin-2-carboxamide | |
JPS6178778A (en) | 4,5-dihydro-4-oxo-2-((2-trans-phenylcyclopropyl)amino) -3-furancarboxylic acid and derivatives | |
Chang et al. | New asparagine analogs | |
NO137999B (en) | ANALOGICAL PROCEDURE FOR THE PREPARATION OF THERAPEUTICALLY ACTIVE OXOFURYLESTERS OF 6- (ALFA-AMINOPHENYLACETAMIDO) PENICILLANIC ACID | |
JPS5949221B2 (en) | Method for producing 3-acylamino-4-homoisotwistane | |
US2519530A (en) | Biotin aliphatic amides and method for their preparation | |
US4062847A (en) | Process for preparing orotic acid | |
SU524804A1 (en) | Method for preparing o, o-dialkyl- (2-aminoethyl) dithiophosphates | |
US3245998A (en) | Processes for the production of picolinic acid dericatives | |
SU730303A3 (en) | Method of preparing thiazolidine carboxylic acids or their acid-additive salts | |
SU999974A3 (en) | Process for producing condensed derivatives of pyrimidine or their salts | |
SU471723A3 (en) | The method of obtaining derivatives of penicillin | |
SU454739A3 (en) | Method for preparing 5 (6) -acylbenzimidazolyl alkyl carbamates | |
JPS6261966A (en) | Propionamidine derivatives and manufacture | |
US3813415A (en) | Process for the preparation of 3-(beta dialkylamino-ethyl)-4-alkyl-7-carboethoxymethoxycoumarins | |
JPS6028827B2 (en) | Method for producing 1-amidinopiperazine | |
SU443027A1 (en) | The method of obtaining arylhydrazide of nitromucuric acid | |
SU516354A3 (en) | Method for preparing furancarboxylic pyridylamides or their salts | |
SU531807A1 (en) | Method for preparing imidazo / 1,2-b / ac-triazinone-2 derivatives | |
US4013673A (en) | 2,3-dihydro-3-(2-pyridinyl)-4h-1-benzopyran-4-one n-oxides | |
US4113950A (en) | Process for preparing orotic acid and thioorotic acid | |
US667381A (en) | Xanthin homologue and process of making same. | |
RU1773905C (en) | Method of obtaining 4,9-dioxa-6-dodecyn-1,12-disylfonate |